FINAL DISPOSITION ON EXTENSION OF PROTECTION

The table below presents the data as entered.

Input Field
Entered
IDENTIFICATION SECTION
INTERNATIONAL REGISTRATION NUMBER0691183
OFFICE REFERENCE 79314220
ORIGINAL LANGUAGE CODEENGLISH
FILE SECTION
FILE SPECIFICATION OF THE DOCUMENTThe legal letter below is sent to IB
GOODS AND SERVICES SECTION
NICE CLASS NUMBER05
LIMITED LISTList limited to
GOODS AND SERVICE TERMS IN ORIGINAL LANGUAGEPharmaceuticals for the treatment of hepatitis B and hepatitis C
INSTRUCTIONS SECTION
FREE TEXT PROCESSING INSTRUCTIONSRegistration of REP Application


USPTO logo
Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451
www.uspto.gov


Statement of Partial Grant of Protection Following a Provisional Refusal
by the United States Patent & Trademark Office
According to Rule 18ter(2)(ii) of the Common Regulations

The United States Patent and Trademark Office hereby notifies the International Bureau of the GRANT OF PROTECTION in the United States for:

International Registration No.: 0691183
Holder: pharma& Schweiz GmbH
Mark: PEGASYS

Application Serial No. 79314220 was registered by the USPTO on August 02, 2022. The registration number is 6805591.

The grant of protection applies to the goods and/or services listed below:

     International Class: 05
     Goods and Services: Pharmaceuticals for the treatment of hepatitis B and hepatitis C